Home/Filings/4/0001209191-22-055109
4//SEC Filing

Paykel Neela 4

Accession 0001209191-22-055109

CIK 0001833769other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 5:55 PM ET

Size

17.7 KB

Accession

0001209191-22-055109

Insider Transaction Report

Form 4
Period: 2022-10-31
Paykel Neela
Gen Counsel & Corp Secretary
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-10-3185,0000 total
    Exercise: $3.90Exp: 2032-02-09Class A Common Stock (85,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-10-3171,7500 total
    Exercise: $3.90Exp: 2032-02-09Class A Common Stock (71,750 underlying)
  • Award

    Stock Option (right to buy)

    2022-10-31+71,75071,750 total
    Exercise: $0.91Exp: 2032-02-09Class A Common Stock (71,750 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-10-3198,2500 total
    Exercise: $3.27Exp: 2031-04-27Class A Common Stock (98,250 underlying)
  • Award

    Stock Option (right to buy)

    2022-10-31+85,00085,000 total
    Exercise: $0.91Exp: 2032-02-09Class A Common Stock (85,000 underlying)
  • Award

    Stock Option (right to buy)

    2022-10-31+98,25098,250 total
    Exercise: $0.91Exp: 2031-04-27Class A Common Stock (98,250 underlying)
Footnotes (3)
  • [F1]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 25,411 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.
  • [F2]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.
  • [F3]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 30,702 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.

Issuer

Hyperfine, Inc.

CIK 0001833769

Entity typeother

Related Parties

1
  • filerCIK 0001894593

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 5:55 PM ET
Size
17.7 KB